Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Xiamen Amoytop Biotech CoSHSE:688278 +2.94%75 Days Payable is 113.83 as of Mar. 2026, which is 34% above its 10-year median of 85.13. GuruFocus rates SHSE:688278 with a GF Score™ of 75/100 and a GF Value™ of ¥106.91 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, Xiamen Amoytop Biotech Co ranks worse than 51.36% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688278 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Xiamen Amoytop Biotech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xiamen Amoytop Biotech Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Xiamen Amoytop Biotech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Xiamen Amoytop Biotech Co's Days Payable falls into.
Xiamen Amoytop Biotech Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Xiamen Amoytop Biotech Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xiamen Amoytop Biotech Co (SHSE:688278) has a Days Payable of 113.83 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xiamen Amoytop Biotech Co and its competitors. This is 34% above median its historical median of 85.13. Over the past decade, Xiamen Amoytop Biotech Co's Days Payable has ranged from 31.05 to 179.79. According to the industry distribution chart, Xiamen Amoytop Biotech Co ranks #360 out of 701 companies in the Biotechnology industry, placing it in the top 51.4%.
Is Xiamen Amoytop Biotech Co's Days Payable too high?
Xiamen Amoytop Biotech Co's current Days Payable of 113.83 is 34% above median its 10-year median of 85.13. Over the past 10 years, this metric has ranged from a low of 31.05 to a high of 179.79. The Biotechnology industry median Days Payable is 113.36. Xiamen Amoytop Biotech Co's value of 113.83 is 0.4% above this industry median. Based on the distribution chart, Xiamen Amoytop Biotech Co ranks #360 out of 701 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Xiamen Amoytop Biotech Co has a GF Score™ of 75/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xiamen Amoytop Biotech Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Xiamen Amoytop Biotech Co ranks #360 out of 701 companies for Days Payable. This places Xiamen Amoytop Biotech Co in the lower half of its industry. The industry median Days Payable is 113.36. Xiamen Amoytop Biotech Co's value of 113.83 is 0.4% above this benchmark. Historically, Xiamen Amoytop Biotech Co's own Days Payable has ranged from 31.05 to 179.79 over the past decade. While the company's 10-year median is 85.13 vs. the industry median of 113.36, Xiamen Amoytop Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiamen Amoytop Biotech Co's current Days Payable of 113.83 is 0.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Xiamen Amoytop Biotech Co and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiamen Amoytop Biotech Co's current Days Payable is 113.83, which is 34% above median its own 10-year median of 85.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiamen Amoytop Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co (SHSE:688278) is currently considered Possible Value Trap. The stock's GF Value™ is ¥106.91, compared to a current price of ¥60.63 — trading 43.3% below its estimated fair value. The current Days Payable is 113.83, which is 34% above median its 10-year median of 85.13 and 0.4% above the Biotechnology industry median of 113.36. Xiamen Amoytop Biotech Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Xiamen Amoytop Biotech Co (SHSE:688278), the current Days Payable is 113.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xiamen Amoytop Biotech Co (SHSE:688278) Overvalued in 2026?
Based on GuruFocus' analysis, Xiamen Amoytop Biotech Co stock appears to be undervalued.
The current stock price of ¥60.63 is trading 43.3% below its estimated GF Value™ of ¥106.91.
GuruFocus considers Xiamen Amoytop Biotech Co to be Possible Value Trap.
Key valuation signals for SHSE:688278:
Days Payable: 113.83 (34% above median its 10-year median of 85.13)
GF Value™: ¥106.91 vs. price of ¥60.63 (43.3% below fair value)
Industry Position: 0.4% above the Biotechnology median (#360 of 701)
No single metric tells the full story. See the SHSE:688278 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
75GF Score
Get the complete analysis for SHSE:688278
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688278 has been successfully added to your 
